sv3asr
As filed with the Securities and Exchange Commission on
April 18, 2007
Registration
No. 333-
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
Form S-3
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF
1933
NUANCE COMMUNICATIONS,
INC.
(Exact name of registrant as
specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
94-3156479
(I.R.S. Employer Identification
Number)
1 Wayside Road
Burlington, MA 01803
(781) 565-5000
(Address, including zip code,
and telephone number, including area code, of registrants
principal executive offices)
James R.
Arnold, Jr.
Chief Financial
Officer
Nuance Communications,
Inc.
1 Wayside Road
Burlington, MA 01803
(781) 565-5000
(Name, address, including zip
code, and telephone number, including area code, of agent for
service)
Copies to:
|
|
|
Jo-Anne Sinclair, Esq.
Vice President and General Counsel
Nuance Communications, Inc.
1 Wayside Road
Burlington, Massachusetts 01803
(781) 565-5000
|
|
Katharine A.
Martin, Esq.
Robert Sanchez, Esq.
Adam M. Dinow, Esq.
Wilson Sonsini Goodrich & Rosati
Professional Corporation
650 Page Mill Road
Palo Alto, CA 94304
(650) 493-9300
|
Approximate date of commencement of proposed sale to the
public: As soon as practicable after the
effective date of this Registration Statement.
If the only securities being registered on this Form are being
offered pursuant to dividend or interest reinvestment plans,
please check the following
box. o
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to
Rule 415 under the Securities Act of 1933, other than
securities offered only in connection with dividend or interest
reinvestment plans, check the following
box. þ
If this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act,
please check the following box and list the Securities Act
registration statement number of the earlier effective
registration statement for the same
offering. o
If this Form is a post-effective amendment filed pursuant to
Rule 462(c) under the Securities Act, check the following
box and list the Securities Act registration statement number of
the earlier effective statement for the same
offering. o
If this Form is a registration statement pursuant to General
Instruction I.D. or a post-effective amendment thereto that
shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the
following box. þ
If this Form is a post-effective amendment to a registration
statement filed pursuant to General Instruction I.D. filed to
register additional securities or additional classes of
securities pursuant to Rule 413(b) under the Securities
Act, check the following box. o
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of Each Class
|
|
|
Amount
|
|
|
Proposed Maximum
|
|
|
Proposed Maximum
|
|
|
Amount of
|
of Securities to
|
|
|
to be
|
|
|
Offering Price
|
|
|
Aggregate Offering
|
|
|
Registration
|
be Registered
|
|
|
Registered(1)
|
|
|
per Share(2)
|
|
|
Price(2)
|
|
|
Fee
|
Common Stock par value
$0.001 per share
|
|
|
522,884
|
|
|
$16.08
|
|
|
$8,407,975
|
|
|
$258.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Pursuant to Rule 416 under the
Securities Act, this Registration Statement shall also cover any
additional shares of Nuance Communications, Inc.s
common stock that become issuable by reason of any stock split,
stock dividend, recapitalization or other similar transaction.
|
|
(2)
|
|
Estimated solely for the purpose of
computing the registration fee and based on the average high and
low sale prices of the common stock of Nuance Communications,
Inc. as reported on the Nasdaq Global Select Market on
April 12, 2007 in accordance with Rule 457(c) under
the Securities Act.
|
PROSPECTUS
DATED
APRIL 18, 2007
522,884
SHARES
Common
Stock
The selling stockholders of Nuance Communications, Inc.
(Nuance, we, or the Company)
listed on
pages 16-17
may offer and resell up to 522,884 shares of Nuance common
stock under this prospectus. We will not receive any proceeds
from such resales by the selling stockholders. The selling
stockholders acquired these shares from us pursuant to an
Agreement and Plan of Merger, dated December 5, 2006, by
and among Nuance, Mobile Voice Control, Inc., (Mobile
Voice Control or MVC) a Delaware corporation,
Mercury Merger Sub, Inc., a Delaware corporation and
wholly-owned subsidiary of Nuance, Mercury Merger Sub LLC, a
Delaware limited liability company and wholly-owned subsidiary
of Nuance, and John J. Kuntz, as Stockholder Representative, in
connection with our acquisition of MVC. The selling stockholders
(which term as used herein includes their respective pledgees,
donees, transferees or other
successors-in-interest)
may sell these shares through public or private transactions at
market prices prevailing at the time of sale or at negotiated
prices. We will not receive any proceeds from the sale of the
shares by the selling stockholders.
Our common stock is listed on the Nasdaq Global Select Market
under the symbol NUAN. On April 17, 2007, the
last reported sale price for our common stock on the Nasdaq
Global Select Market was $16.78 per share.
Investing in our common stock involves risks.
See Risk Factors beginning on page 4.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE
SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE
SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR
COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
The date of this prospectus is April 18, 2007
TABLE OF
CONTENTS
No dealer, salesperson or other person is authorized to give
any information or to represent anything not contained in this
prospectus. You must not rely on any unauthorized information or
representations. This prospectus is an offer to sell only the
shares offered hereby, but only under circumstances and in
jurisdictions where it is lawful to do so. The information
contained in this prospectus is current only as of its date.
PROSPECTUS
SUMMARY
This summary highlights selected information contained
elsewhere in this prospectus. This summary does not contain all
the information that you should consider before investing in our
common stock. You should read the following summary together
with the more detailed information regarding our company, the
common stock being registered hereby, and our financial
statements and notes thereto incorporated by reference in this
prospectus.
FORWARD
LOOKING STATEMENTS
This prospectus, including the sections entitled
Prospectus Summary and Risk Factors,
contains forward looking statements within the meaning of
Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act of 1934, and within the safe harbor
provisions of the Private Securities Litigation Reform Act of
1995. These statements relate to future events or our future
financial performance and involve known and unknown risks,
uncertainties and other factors that may cause our or our
industrys actual results, levels of activity, performance
or achievements to be materially different from any future
results, levels of activity, performance or achievements
expressed or implied by the forward looking statements. These
risks and other factors include those listed under Risk
Factors and elsewhere in this prospectus. In some cases,
you can identify forward looking statements by terminology such
as may, will, should,
expects, plans, anticipates,
believes, estimates,
predicts, potential,
continue or the negative of these terms or other
comparable terminology. These statements are only predictions.
In evaluating these statements, you should specifically consider
various factors, including the risks outlined under Risk
Factors.
Although we believe that the expectations reflected in the
forward looking statements are reasonable, we cannot guarantee
future results, levels of activity, performance or achievements.
Moreover, neither we nor any other person assumes responsibility
for the accuracy and completeness of these forward looking
statements. We are under no duty to update any of the forward
looking statements after the date of this prospectus to conform
our prior statements to actual results
Overview
Nuance is a leading provider of speech and imaging solutions for
businesses and consumers around the world. Nuance offers
businesses and consumers market-leading speech and imaging
solutions that facilitate the way people access, share, manage
and use information in business and in daily life. We market and
distribute our products indirectly through a global network of
resellers comprising system integrators, independent software
vendors, value-added resellers, hardware vendors,
telecommunications carriers and distributors; and directly to
businesses and consumers through a dedicated direct sales force
and our
e-commerce
website (www.nuance.com). The value of our solutions is
best realized in markets that are information and
process-intensive, such as healthcare, telecommunications,
financial services, legal services and government
administration. We deliver premier, comprehensive technologies
and services as an independent application or as part of a
larger integrated system. We are an active participant in
rapidly growing markets for speech, including healthcare
dictation and transcription, call center automation, mobile
search and communication and embedded technologies for consumer
products. In imaging, we are positioned to benefit from
increasing demand for PDF and networked imaging solutions.
Nuance was incorporated in 1992 as Visioneer, Inc. In 1999, we
changed our name to ScanSoft, Inc. and also changed our ticker
symbol to SSFT. In October 2004, we changed our fiscal year end
to September 30, resulting in a nine-month fiscal year for
2004. In October 2005, we changed our name to Nuance
Communications, Inc., to reflect our core mission of being the
worlds most comprehensive and innovative provider of
speech solutions, and in November 2005 we changed our ticker
symbol to NUAN. Our corporate headquarters and executive offices
are located at 1 Wayside Road, Burlington, Massachusetts 01803.
Our telephone number is
781-565-5000.
Our Annual Reports on
Form 10-K,
Quarterly Reports on
Form 10-Q,
Proxy Statements relating to our annual meetings of
stockholders, Current Reports on
Form 8-K
and
1
amendments to these reports are available free of charge on our
website at www.nuance.com, as well as from the SEC
website at www.sec.gov.
Background
From our founding in 1992 until December 2001, we focused
exclusively on delivering imaging solutions that simplified
converting and managing information as it moved from paper
formats to electronic systems. On March 13, 2000, we merged
with Caere Corporation, a California-based digital imaging
software company, to expand our applications for document and
electronic forms conversion. In December 2001, we entered the
speech market through the acquisition of the Speech &
Language Technology Business from Lernout & Hauspie. We
believed speech solutions were a natural complement to our
imaging solutions as both are developed, marketed and delivered
through similar resources and channels. We continue to execute
against our strategy of being the market leader in speech
solutions through the organic growth of our business as well as
through strategic acquisitions. We have successfully completed
17 acquisitions since 2000 and we expect to continue to make
acquisitions of other companies, businesses and technologies to
complement our internal investments. In recent fiscal years, we
completed a number of acquisitions, including:
|
|
|
|
|
On January 30, 2003, we acquired Royal Philips Electronics
Speech Processing Telephony and Voice Control business units to
expand our solutions for speech in call centers and within
automobiles and mobile devices.
|
|
|
|
On August 11, 2003, we acquired SpeechWorks International,
Inc. to broaden our speech applications for telecommunications,
call centers and embedded environments as well as establish a
professional services organization.
|
|
|
|
On February 1, 2005, we acquired Phonetic Systems Ltd. to
complement our solutions and expertise in automated directory
assistance and enterprise speech applications.
|
|
|
|
On September 15, 2005, we acquired the former Nuance
Communications, Inc., which we refer to as Former Nuance, to
expand our portfolio of technologies, applications and services
for call center automation, customer self service and directory
assistance.
|
|
|
|
On March 31, 2006, we acquired Dictaphone Corporation, a
leading healthcare information technology company that provides
a broad range of digital dictation, transcription, and report
management system solutions.
|
|
|
|
On December 29, 2006, we acquired Mobile Voice Control to
further enhance our deployment of speech-enabled solutions in
the wireless industry.
|
|
|
|
On March 26, 2007, we acquired Bluestar Resources Limited,
the parent of Focus Enterprises Limited and Focus Infosys India
Private Limited (collectively, Focus) to expand our
ability to deliver Web-based speech recognition editing services.
|
In addition, on February 22, 2007, we entered into an
agreement to acquire BeVocal, Inc. (BeVocal) in
order to expand our position as a leading supplier of speech
enabled solutions to mobile carriers and their customers.
Our
Strategy
We focus on providing competitive and value-added solutions for
our customers and partners through a broad set of technologies,
service offerings and channel capabilities. To continue to
provide industry leading solutions, through acquisitions and
organic growth, we intend to:
Participate Broadly In Speech. We intend to
leverage our comprehensive technologies and leadership in speech
to expand our opportunities in the call center, automotive,
healthcare, telecommunications and mobile markets. We also
intend to pursue emerging opportunities to use our speech
technologies within consumer devices, games and other embedded
applications. To expand our position in speech, we intend to
introduce new versions of our products and applications complete
new license agreements with
2
customers and partners that will resell our technologies. We
also intend to continue to make strategic acquisitions that we
believe complement our existing capabilities in the
telecommunications, automotive and electronics markets.
Pursue Opportunities for Dictation and Transcription in
Healthcare. We intend to increase our investments
and efforts in providing dictation solutions to the healthcare
market, where we believe there is a large and attractive
opportunity to automate transcription processes and information
workflow. We have formed a healthcare-specific sales
organization to aggressively pursue sales into healthcare
provider organizations, expanded our reseller and system
integrator channels within healthcare, and entered into OEM
license agreements with leading healthcare IT hardware and
software vendors.
Pursue Strategic Acquisitions. We have
selectively pursued strategic acquisitions to expand our
technology, channel and service resources and to complement our
organic growth. We expect to continue to make acquisitions of
other companies, businesses and technologies to complement our
existing capabilities and our internal investments in these
areas and have a team that focuses on evaluating market needs
and potential acquisitions to fulfill them. We have a
disciplined methodology for integrating acquired companies and
businesses after the transaction is complete.
Expand Worldwide Channels. We intend to expand
our global channel network and build upon our existing
distribution channels, especially in Europe, Asia and Latin
America. Along these lines, we have added sales employees in
different geographic regions and launched programs and events to
help recruit new partners for our channel network.
Expand PDF and Imaging Solutions. We intend to
enhance the value and functionality of our PDF and imaging
solutions to enable enterprises to address the proliferation of
PDF, the expanded use of content management systems and the
widespread adoption of networked multifunction and digital
scanning devices. We intend to continue to introduce new and
improved versions of our products to take advantage of
developing market opportunities. We also plan to enhance our
software development toolkits so our technologies can be
integrated with more third-party and OEM solutions.
The
Shares Offered in this Prospectus
|
|
|
Common stock offered |
|
522,884 shares |
|
Our common stock is listed on the Nasdaq Global Select Market
under the symbol |
|
NUAN |
|
Use of proceeds |
|
All of the shares of common stock being offered under this
prospectus are being sold by the selling stockholders or their
pledges, donees, transferees or other successors in interest.
Accordingly, we will not receive any proceeds from the sale of
these shares. |
3
RISK
FACTORS
You should carefully consider the risks described below,
together with all of the other information included in or
incorporated by reference into this prospectus, before making an
investment decision. The risks and uncertainties described below
are not the only ones we face. Additional risks and
uncertainties not presently known to us or that we do not
currently believe are important to an investor may also harm our
business operations. If any of the events, contingencies,
circumstances or conditions described in the following risks
actually occurs, our business, financial condition or our
results of operations could be seriously harmed. If that
happens, the trading price of our common stock could decline and
you may lose part or all of the value of any of our shares held
by you.
Risks
Related to Our Business
Our
operating results may fluctuate significantly from period to
period, and this may cause our stock price to
decline.
Our revenue and operating results have fluctuated in the past
and we expect our revenue and operating results to continue to
fluctuate in the future. Given this fluctuation, we believe that
quarter to quarter comparisons of our revenue and operating
results are not necessarily meaningful or an accurate indicator
of our future performance. As a result, our results of
operations may not meet the expectations of securities analysts
or investors in the future. If this occurs, the price of our
stock would likely decline. Factors that contribute to
fluctuations in our operating results include the following:
|
|
|
|
|
slowing sales by our distribution and fulfillment partners to
their customers, which may place pressure on these partners to
reduce purchases of our products;
|
|
|
|
volume, timing and fulfillment of customer orders;
|
|
|
|
our efforts to generate additional revenue from our portfolio of
intellectual property;
|
|
|
|
concentration of operations with one manufacturing partner and
ability to control expenses related to the manufacture,
packaging and shipping of our boxed software products;
|
|
|
|
customers delaying their purchasing decisions in anticipation of
new versions of our products;
|
|
|
|
customers delaying, canceling or limiting their purchases as a
result of the threat or results of terrorism;
|
|
|
|
introduction of new products by us or our competitors;
|
|
|
|
seasonality in purchasing patterns of our customers;
|
|
|
|
reduction in the prices of our products in response to
competition or market conditions;
|
|
|
|
returns and allowance charges in excess of accrued amounts;
|
|
|
|
timing of significant marketing and sales promotions;
|
|
|
|
impairment charges against goodwill and other intangible assets;
|
|
|
|
write-offs of excess or obsolete inventory and accounts
receivable that are not collectible;
|
|
|
|
increased expenditures incurred pursuing new product or market
opportunities;
|
|
|
|
general economic trends as they affect retail and corporate
sales; and
|
|
|
|
higher than anticipated costs related to fixed-price contracts
with our customers.
|
Due to the foregoing factors, among others, our revenue and
operating results are difficult to forecast. Our expense levels
are based in significant part on our expectations of future
revenue, and we may not be able to reduce our expenses quickly
to respond to a shortfall in projected revenue. Therefore, our
failure to meet revenue expectations would seriously harm our
operating results, financial condition and cash flows.
4
We
have grown, and may continue to grow, through acquisitions,
which could dilute our existing shareholders and could involve
substantial integration risks.
As part of our business strategy, we have in the past acquired,
and expect to continue to acquire, other businesses and
technologies. In connection with past acquisitions, we issued a
substantial number of shares of our common stock as transaction
consideration and also incurred significant debt to finance the
cash consideration used for our acquisition of Dictaphone
Corporation, Focus and our pending acquisition of BeVocal. We
may continue to issue equity securities for future acquisitions,
which would dilute our existing stockholders, perhaps
significantly depending on the terms of the acquisition. We may
also incur additional debt in connection with future
acquisitions, which, if available at all, may place additional
restrictions on our ability to operate our business.
Furthermore, our prior acquisitions required substantial
integration and management efforts. Acquisitions of this nature
involve a number of risks, including:
|
|
|
|
|
difficulty in transitioning and integrating the operations and
personnel of the acquired businesses, including different and
complex accounting and financial reporting systems;
|
|
|
|
potential disruption of our ongoing business and distraction of
management;
|
|
|
|
potential difficulty in successfully implementing, upgrading and
deploying in a timely and effective manner new operational
information systems and upgrades of our finance, accounting and
product distribution systems;
|
|
|
|
difficulty in incorporating acquired technology and rights into
our products and technology;
|
|
|
|
unanticipated expenses and delays in completing acquired
development projects and technology integration;
|
|
|
|
management of geographically remote units both in the United
States and internationally;
|
|
|
|
impairment of relationships with partners and customers;
|
|
|
|
customers delaying purchases of our products pending resolution
of product integration between our existing and our newly
acquired products;
|
|
|
|
entering markets or types of businesses in which we have limited
experience; and
|
|
|
|
potential loss of key employees of the acquired company.
|
As a result of these and other risks, we may not realize
anticipated benefits from our acquisitions. Any failure to
achieve these benefits or failure to successfully integrate
acquired businesses and technologies could seriously harm our
business.
Purchase
accounting treatment of our acquisitions could decrease our net
income in the foreseeable future, which could have a material
and adverse effect on the market value of our common
stock.
Under accounting principles generally accepted in the United
States of America, we have accounted for our acquisitions using
the purchase method of accounting. Under purchase accounting, we
record the market value of our common stock or other form of
consideration issued in connection with the acquisition and the
amount of direct transaction costs as the cost of acquiring the
company or business. We have allocated that cost to the
individual assets acquired and liabilities assumed, including
various identifiable intangible assets such as acquired
technology, acquired trade names and acquired customer
relationships based on their respective fair values. Intangible
assets generally will be amortized over a five to ten year
period. Goodwill and certain intangible assets with indefinite
lives, are not subject to amortization but are subject to at
least an annual impairment analysis, which may result in an
impairment charge if the carrying value exceeds its implied fair
value. As of December 31, 2006, we had identified
intangible assets amounting to approximately $217.2 million
and goodwill of approximately $705.4 million.
5
Our
significant debt could adversely affect our financial health and
prevent us from fulfilling our obligations under our credit
facility.
We have a significant amount of debt. On April 5, 2007, we
entered into an amended and restated credit facility which
consists of a $442.0 million term loan due March 2013 and a
$75.0 million revolving credit line due March 2012. Our
debt level could have important consequences, for example it
could:
|
|
|
|
|
require us to use of a large portion of our cash flow to pay
principal and interest on the credit facility, which will reduce
the availability of our cash flow to fund working capital,
capital expenditures, research and development expenditures and
other business activities;
|
|
|
|
restrict us from making strategic acquisitions or exploiting
business opportunities;
|
|
|
|
place us at a competitive disadvantage compared to our
competitors that have less debt; and
|
|
|
|
limit, along with the financial and other restrictive covenants
in our debt, our ability to borrow additional funds, dispose of
assets or pay cash dividends.
|
In addition, a substantial portion of our debt bears interest at
variable rates. If market interest rates increase, our debt
service requirements will increase, which would adversely affect
our cash flow. While we have entered into an interest rate swap
agreement limiting our exposure for a portion of our debt, such
agreement does not offer complete protection from this risk.
We
have a history of operating losses, and we may incur losses in
the future, which may require us to raise additional capital on
unfavorable terms.
We reported net losses of approximately $1.2 million for
the fiscal quarter ended December 31, 2006 and
$22.9 million, $5.4 million and $9.4 million for
fiscal years 2006, 2005 and 2004, respectively. We had an
accumulated deficit of approximately $191.4 million at
December 31, 2006. If we are unable to achieve and maintain
profitability, the market price for our stock may decline,
perhaps substantially. We cannot assure you that our revenue
will grow or that we will achieve or maintain profitability in
the future. If we do not achieve profitability, we may be
required to raise additional capital to maintain or grow our
operations. The terms of any additional capital, if available at
all, may be highly dilutive to existing investors or contain
other unfavorable terms, such as a high interest rate and
restrictive covenants.
We
depend on limited or sole source suppliers for critical
components. The inability to obtain sufficient components as
required, and under favorable purchase terms, would harm our
business.
We are dependent on certain suppliers, including limited and
sole source suppliers, to provide key components used in our
products. We have experienced, and may continue to experience,
delays in component deliveries, which in turn could cause delays
in product shipments and require the redesign of certain
products. In addition, if we are unable to procure necessary
components under favorable purchase terms, including at
favorable prices and with the order lead-times needed for the
efficient and profitable operation of our business, our results
of operations could suffer.
Speech
technologies may not achieve widespread acceptance by
businesses, which could limit our ability to grow our speech
business.
We have invested and expect to continue to invest heavily in the
acquisition, development and marketing of speech technologies.
The market for speech technologies is relatively new and rapidly
evolving. Our ability to increase revenue in the future depends
in large measure on acceptance of speech technologies in general
and our products in particular. The continued development of the
market for our current and future speech solutions will also
depend on the following factors:
|
|
|
|
|
consumer demand for speech-enabled applications;
|
|
|
|
development by third-party vendors of applications using speech
technologies; and
|
|
|
|
continuous improvement in speech technology.
|
6
Sales of our speech products would be harmed if the market for
speech technologies does not continue to develop or develops
more slowly than we expect, and, consequently, our business
could be harmed and we may not recover the costs associated with
our investment in our speech technologies.
The
markets in which we operate are highly competitive and rapidly
changing, and we may be unable to compete
successfully.
There are a number of companies that develop or may develop
products that compete in our targeted markets. The individual
markets in which we compete are highly competitive, and are
rapidly changing. Within imaging, we compete directly with
ABBYY, Adobe, I.R.I.S. and NewSoft. Within speech, we compete
with AT&T, Fonix, IBM, Microsoft and Philips. Within
healthcare dictation and transcription, we compete with Philips
Medical, Spheris and other smaller providers. In speech, some of
our partners such as Avaya, Cisco, Edify, Genesys and Nortel
develop and market products that can be considered substitutes
for our solutions. In addition, a number of smaller companies in
both speech and imaging produce technologies or products that
are in some markets competitive with our solutions. Current and
potential competitors have established, or may establish,
cooperative relationships among themselves or with third parties
to increase the ability of their technologies to address the
needs of our prospective customers.
The competition in these markets could adversely affect our
operating results by reducing the volume of the products we
license or the prices we can charge. Some of our current or
potential competitors, such as Adobe, IBM and Microsoft, have
significantly greater financial, technical and marketing
resources than we do. These competitors may be able to respond
more rapidly than we can to new or emerging technologies or
changes in customer requirements. They may also devote greater
resources to the development, promotion and sale of their
products than we do.
Some of our customers, such as IBM and Microsoft, have developed
or acquired products or technologies that compete with our
products and technologies. These customers may give higher
priority to the sale of these competitive products or
technologies. To the extent they do so, market acceptance and
penetration of our products, and therefore our revenue, may be
adversely affected.
Our success will depend substantially upon our ability to
enhance our products and technologies and to develop and
introduce, on a timely and cost-effective basis, new products
and features that meet changing customer requirements and
incorporate technological advancements. If we are unable to
develop new products and enhance functionalities or technologies
to adapt to these changes, or if we are unable to realize
synergies among our acquired products and technologies, our
business will suffer.
The
failure to successfully maintain the adequacy of our system of
internal control over financial reporting could have a material
adverse impact on our ability to report our financial results in
an accurate and timely manner.
Our managements assessment of the effectiveness of our
internal control over financial reporting, as of
September 30, 2005, identified a material weakness in our
internal controls related to tax accounting, primarily as a
result of a lack of necessary corporate accounting resources and
ineffective execution of certain controls designed to prevent or
detect actual or potential misstatements in the tax accounts.
While we have taken remediation measures to correct this
material weakness, which measures are more fully described in
Item 9A of our Annual Report on
Form 10-K/A,
we cannot assure you that we will not have material weaknesses
in our internal controls in the future. Any failure in the
effectiveness of our system of internal control over financial
reporting could have a material adverse impact on our ability to
report our financial results in an accurate and timely manner.
A
significant portion of our revenue and a significant portion of
our research and development are conducted internationally. Our
results could be harmed by economic, political, regulatory and
other risks associated with these international
regions.
Because we license our products worldwide, our business is
subject to risks associated with doing business internationally.
We anticipate that revenue from international operations will
continue to increase in
7
the remainder of fiscal 2007. Reported international revenue,
classified by the major geographic areas in which our customers
are located, represented approximately $31.9 million for
the fiscal quarter ended December 31, 2006 and
approximately $100.2 million, $71.5 million and
$39.4 million, for fiscal 2006, 2005 and 2004 respectively.
Most of our international revenue is generated by sales in
Europe and Asia. In addition, some of our products are developed
and manufactured outside the United States. A significant
portion of the development and manufacturing of our speech
products are completed in Belgium, and a significant portion of
our imaging research and development is conducted in Hungary. In
connection with prior acquisitions we have added research and
development resources in Aachen, Germany, Montreal, Canada and
Tel Aviv, Israel. Accordingly, our future results could be
harmed by a variety of factors associated with international
sales and operations, including:
|
|
|
|
|
changes in a specific countrys or regions economic
conditions;
|
|
|
|
geopolitical turmoil, including terrorism and war;
|
|
|
|
trade protection measures and import or export licensing
requirements imposed by the United States or by other countries;
|
|
|
|
compliance with foreign and domestic laws and regulations;
|
|
|
|
|
|
negative consequences from changes in applicable tax laws;
|
|
|
|
difficulties in staffing and managing operations in multiple
locations in many countries;
|
|
|
|
difficulties in collecting trade accounts receivable in other
countries; and
|
|
|
|
less effective protection of intellectual property.
|
We are
exposed to fluctuations in foreign currency exchange
rates.
Because we have international subsidiaries and distributors that
operate and sell our products outside the United States, we are
exposed to the risk of changes in foreign currency exchange
rates or declining economic conditions in these countries. In
certain circumstances, we have entered into forward exchange
contracts to hedge against foreign currency fluctuations on
intercompany balances with our foreign subsidiaries. We use
these contracts to reduce our risk associated with exchange rate
movements, as the gains or losses on these contracts are
intended to offset any exchange rate losses or gains on the
hedged transaction. We do not engage in foreign currency
speculation. Hedges are designated and documented at the
inception of the hedge and are evaluated for effectiveness
monthly. Forward exchange contracts hedging firm commitments
qualify for hedge accounting when they are designated as a hedge
of the foreign currency exposure and they are effective in
minimizing such exposure. With our increased international
presence in a number of geographic locations and with
international revenue projected to increase in the remainder of
fiscal 2007, we are exposed to changes in foreign currencies
including the Euro, British Pound, Canadian Dollar, Japanese
Yen, Israeli New Shekel and the Hungarian Forint. Changes in the
value of the Euro or other foreign currencies relative to the
value of the U.S. dollar could adversely affect future
revenue and operating results.
Impairment
of our intangible assets could result in significant charges
which would adversely impact our future operating
results.
We have significant intangible assets, including goodwill and
intangibles with indefinite lives, which are susceptible to
valuation adjustments as a result of changes in various factors
or conditions. The most significant intangible assets are
patents and core technology, completed technology, customer
relationships and trademarks. Customer relationships are
amortized on an accelerated basis based upon the pattern in
which the economic benefit of customer relationships are being
utilized. Other identifiable intangible assets are amortized on
a straight-line basis over their estimated useful lives. We
assess the potential impairment of identifiable intangible
assets whenever events or changes in circumstances indicate that
the carrying value may not be recoverable. Factors which could
trigger an impairment of such assets, include the following:
|
|
|
|
|
significant underperformance relative to historical or projected
future operating results;
|
8
|
|
|
|
|
significant changes in the manner of or use of the acquired
assets or the strategy for our overall business;
|
|
|
|
significant negative industry or economic trends;
|
|
|
|
significant decline in our stock price for a sustained
period; and
|
|
|
|
a decline in our market capitalization below net book value.
|
Future adverse changes in these or other unforeseeable factors
could result in an impairment charge that would impact our
results of operations and financial position in the reporting
period identified. As of December 31, 2006, we had
identified intangible assets amounting to approximately
$217.2 million and goodwill of approximately
$705.4 million.
If we
are unable to attract and retain key personnel, our business
could be harmed.
If any of our key employees were to leave us, we could face
substantial difficulty in hiring qualified successors and could
experience a loss in productivity while any successor obtains
the necessary training and experience. Our employment
relationships are generally at-will and we have had key
employees leave us in the past. We cannot assure you that one or
more key employees will not leave us in the future. We intend to
continue to hire additional highly qualified personnel,
including software engineers and operational personnel, but we
may not be able to attract, assimilate or retain qualified
personnel in the future. Any failure to attract, integrate,
motivate and retain these employees could harm our business.
Our
medical transcription services may be subject to legal claims
for failure to comply with laws governing the confidentiality of
medical records.
Healthcare professionals who use our medical transcription
services deliver to us health information about their patients
including information that constitutes a record under applicable
law that we may store on our computer systems. Numerous federal
and state laws and regulations, the common law and contractual
obligations govern collection, dissemination, use and
confidentiality of patient-identifiable health information,
including:
|
|
|
|
|
state and federal privacy and confidentiality laws;
|
|
|
|
our contracts with customers and partners;
|
|
|
|
state laws regulating healthcare professionals;
|
|
|
|
Medicaid laws; and
|
|
|
|
the Health Insurance Portability and Accountability Act of 1996
and related rules proposed by the Health Care Financing
Administration.
|
The Health Insurance Portability and Accountability Act of 1996
establishes elements including, but not limited to, federal
privacy and security standards for the use and protection of
protected health information. Any failure by us or by our
personnel or partners to comply with applicable requirements may
result in a material liability to us.
Although we have systems and policies in place for safeguarding
protected health information from unauthorized disclosure, these
systems and policies may not preclude claims against us for
alleged violations of applicable requirements. There can be no
assurance that we will not be subject to liability claims which
could have a material adverse affect on our business, results of
operations and financial condition.
9
Risks
Related to Our Intellectual Property and Technology
Unauthorized
use of our proprietary technology and intellectual property will
adversely affect our business and results of
operations.
Our success and competitive position depend in large part on our
ability to obtain and maintain intellectual property rights
protecting our products and services. We rely on a combination
of patents, copyrights, trademarks, service marks, trade
secrets, confidentiality provisions and licensing arrangements
to establish and protect our intellectual property and
proprietary rights. Unauthorized parties may attempt to copy
aspects of our products or to obtain, license, sell or otherwise
use information that we regard as proprietary. Policing
unauthorized use of our products is difficult and we may not be
able to protect our technology from unauthorized use.
Additionally, our competitors may independently develop
technologies that are substantially the same or superior to ours
and that do not infringe our rights. In these cases, we would be
unable to prevent our competitors from selling or licensing
these similar or superior technologies. In addition, the laws of
some foreign countries do not protect our proprietary rights to
the same extent as the laws of the United States. Although the
source code for our proprietary software is protected both as a
trade secret and as a copyrighted work, litigation may be
necessary to enforce our intellectual property rights, to
protect our trade secrets, to determine the validity and scope
of the proprietary rights of others, or to defend against claims
of infringement or invalidity. Litigation, regardless of the
outcome, can be very expensive and can divert management efforts.
Third
parties have claimed and may claim in the future that we are
infringing their intellectual property, and we could be exposed
to significant litigation or licensing expenses or be prevented
from selling our products if such claims are
successful.
From time to time, we are subject to claims that we or our
customers may be infringing or contributing to the infringement
of the intellectual property rights of others. We may be unaware
of intellectual property rights of others that may cover some of
our technologies and products. If it appears necessary or
desirable, we may seek licenses for these intellectual property
rights. However, we may not be able to obtain licenses from some
or all claimants, the terms of any offered licenses may not be
acceptable to us, and we may not be able to resolve disputes
without litigation. Any litigation regarding intellectual
property could be costly and time-consuming and could divert the
attention of our management and key personnel from our business
operations. In the event of a claim of intellectual property
infringement, we may be required to enter into costly royalty or
license agreements. Third parties claiming intellectual property
infringement may be able to obtain injunctive or other equitable
relief that could effectively block our ability to develop and
sell our products.
On November 8, 2006, VoiceSignal Technologies, Inc. filed
an action against us and eleven of our resellers in the United
States District Court for the Western District of Pennsylvania
claiming patent infringement. Damages were sought in an
unspecified amount. In the lawsuit, VoiceSignal alleges that we
are infringing United States Patent No. 5,855,000 which is
related to improving correction in a dictation application based
on a two input analysis. We believe these claims have no merit
and intend to defend the action vigorously.
On May 31, 2006 GTX Corporation (GTX), filed an
action against us in the United States District Court for the
Eastern District of Texas claiming patent infringement. Damages
were sought in an unspecified amount. In the lawsuit, GTX
alleged that we are infringing United States Patent
No. 7,016,536 entitled Method and Apparatus for
Automatic Cleaning and Enhancing of Scanned Documents. We
believe these claims have no merit and intend to defend the
action vigorously.
On November 27, 2002, AllVoice Computing plc
(AllVoice) filed an action against us in the
United States District Court for the Southern District of
Texas claiming patent infringement. In the lawsuit, AllVoice
alleges that we are infringing United States Patent
No. 5,799,273 entitled Automated Proofreading Using
Interface Linking Recognized Words to their Audio Data While
Text is Being Changed (the 273 Patent).
The 273 Patent generally discloses techniques for
manipulating audio data associated with text generated by a
speech recognition engine. Although we have several products in
the speech recognition technology field, we believe that our
products do not infringe the 273 Patent because, in
addition to other defenses, they do not use the claimed
techniques. Damages are sought in an unspecified amount. We
filed an Answer on December 23, 2002.
10
The United States District Court for the Southern District of
Texas entered summary judgment against AllVoice and dismissed
all claims against Nuance on February 21, 2006. AllVoice
filed a notice of appeal from this judgment on April 26,
2006. We believe these claims have no merit and intend to defend
the action vigorously.
We believe that the final outcome of the current litigation
matters described above will not have a significant adverse
effect on our financial position and results of operations.
However, even if our defense is successful, the litigation could
require significant management time and could be costly. Should
we not prevail in these litigation matters, we may be unable to
sell and/or
license certain of our technologies we consider to be
proprietary, and our operating results, financial position and
cash flows could be adversely impacted.
Our
software products may have bugs, which could result in delayed
or lost revenue, expensive correction, liability to our
customers and claims against us.
Complex software products such as ours may contain errors,
defects or bugs. Defects in the solutions or products that we
develop and sell to our customers could require expensive
corrections and result in delayed or lost revenue, adverse
customer reaction and negative publicity about us or our
products and services. Customers who are not satisfied with any
of our products may also bring claims against us for damages,
which, even if unsuccessful, would likely be time-consuming to
defend, and could result in costly litigation and payment of
damages. Such claims could harm our reputation, financial
results and competitive position.
Risks
Related to Our Corporate Structure, Organization and Common
Stock
The
holdings of our two largest stockholders may enable them to
influence matters requiring stockholder approval.
On March 19, 2004, Warburg Pincus, a global private equity
firm agreed to purchase all outstanding shares of our stock held
by Xerox Corporation for approximately $80 million.
Additionally, on May 9, 2005 and September 15, 2005 we
sold shares of common stock, and warrants to purchase common
stock to Warburg Pincus for aggregate gross proceeds of
approximately $75.1 million. As of December 31, 2006,
Warburg Pincus beneficially owned approximately 23% of our
outstanding common stock, including warrants exercisable for up
to 7,066,538 shares of our common stock and
3,562,238 shares of our outstanding Series B Preferred
Stock, each of which is convertible into one share of our common
stock. Franklin Resources, Inc. is our second largest
stockholder, owning approximately 5% of our common stock as of
December 31, 2006. Because of their large holdings of our
capital stock relative to other stockholders, each of these two
stockholders acting individually, or together, have a strong
influence over matters requiring approval by our stockholders.
The
market price of our common stock has been and may continue to be
subject to wide fluctuations.
Our stock price historically has been, and may continue to be,
volatile. Various factors contribute to the volatility of our
stock price, including, for example, quarterly variations in our
financial results, new product introductions by us or our
competitors and general economic and market conditions. While we
cannot predict the individual effect that these factors may have
on the market price of our common stock, these factors, either
individually or in the aggregate, could result in significant
volatility in our stock price during any given period of time.
Moreover, companies that have experienced volatility in the
market price of their stock often are subject to securities
class action litigation. If we were the subject of such
litigation, it could result in substantial costs and divert
managements attention and resources.
Compliance
with changing regulation of corporate governance and public
disclosure may result in additional expenses.
Changing laws, regulations and standards relating to corporate
governance and public disclosure, including the Sarbanes-Oxley
Act of 2002, new regulations promulgated by the Securities and
Exchange Commission and the rules of the NASDAQ Global Select
Market, are resulting in increased general and administrative
expenses for companies such as ours. These new or changed laws,
regulations and standards are subject to varying interpretations
in many cases, and as a result, their application in practice
may evolve over
11
time as new guidance is provided by regulatory and governing
bodies, which could result in higher costs necessitated by
ongoing revisions to disclosure and governance practices. We are
committed to maintaining high standards of corporate governance
and public disclosure. As a result, we have and expect to
continue to invest resources to comply with evolving laws,
regulations and standards, and this investment may result in
increased general and administrative expenses and a diversion of
management time and attention from revenue-generating activities
to compliance activities. If our efforts to comply with new or
changed laws, regulations and standards differ from the
activities intended by regulatory or governing bodies, our
business may be harmed.
We
have implemented anti-takeover provisions, which could
discourage or prevent a takeover, even if an acquisition would
be beneficial to our stockholders.
Provisions of our certificate of incorporation, bylaws and
Delaware law, as well as other organizational documents could
make it more difficult for a third party to acquire us, even if
doing so would be beneficial to our stockholders. These
provisions include:
|
|
|
|
|
authorized blank check preferred stock;
|
|
|
|
prohibiting cumulative voting in the election of directors;
|
|
|
|
limiting the ability of stockholders to call special meetings of
stockholders;
|
|
|
|
requiring all stockholder actions to be taken at meetings of our
stockholders; and
|
|
|
|
establishing advance notice requirements for nominations of
directors and for stockholder proposals.
|
USE OF
PROCEEDS
We will not receive any proceeds from the sale of the common
stock by the selling stockholders.
SELLING
STOCKHOLDERS
Up to 522,884 shares of common stock are being offered by
this prospectus, all of which are being offered for resale for
the account of the selling stockholders. Unless otherwise noted
below, the shares being offered were issued to the selling
stockholders pursuant to an Agreement and Plan of Merger, dated
December 5, 2006, by and among Nuance, MVC and certain
other parties in connection with our acquisition of MVC. The
selling stockholders may from time to time offer and sell
pursuant to this prospectus any or all of the shares of our
common stock being registered.
12
The following table sets forth information for the selling
stockholders as of March 31, 2007. Beneficial ownership is
determined in accordance with the Securities and Exchange
Commission rules and includes securities that the selling
stockholders have the right to acquire within 60 days after
March 31, 2007. Except as otherwise indicated, we believe
that the selling stockholders have sole voting and investment
power with respect to all shares of the common stock shown as
beneficially owned by them. The selling stockholders may from
time to time offer and sell pursuant to this prospectus any or
all of the common stock being registered.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares
|
|
|
|
|
|
Shares
|
|
|
|
Beneficially
|
|
|
|
|
|
Beneficially
|
|
|
|
Owned Prior
|
|
|
Shares
|
|
|
Owned After
|
|
|
|
to the
|
|
|
Being
|
|
|
the
|
|
Name
|
|
Offering(1)
|
|
|
Offered
|
|
|
Offering(2)
|
|
|
Charles E. Allen Jr.
|
|
|
12,570
|
|
|
|
12,570
|
|
|
|
0
|
|
Archdiocese of Cincinnati f/b/o
St. Margaret of York Church
|
|
|
3,430
|
|
|
|
3,430
|
|
|
|
0
|
|
Louis M. Berman
|
|
|
9,157
|
|
|
|
9,157
|
|
|
|
0
|
|
Robert L. Bollin
|
|
|
5,994
|
|
|
|
5,994
|
|
|
|
0
|
|
Stephen S. Burns
|
|
|
109,982
|
|
|
|
109,982
|
|
|
|
0
|
|
R. Brian Chabot
|
|
|
4,495
|
|
|
|
4,495
|
|
|
|
0
|
|
John J. Cummins
|
|
|
6,630
|
|
|
|
6,630
|
|
|
|
0
|
|
Rex G. Fannin
|
|
|
4,495
|
|
|
|
4,495
|
|
|
|
0
|
|
Arlene Keller
|
|
|
6,410
|
|
|
|
6,410
|
|
|
|
0
|
|
Mickey W. Kowitz
|
|
|
107,335
|
|
|
|
107,335
|
|
|
|
0
|
|
John J. Kuntz
|
|
|
6,243
|
|
|
|
6,243
|
|
|
|
0
|
|
The Legion of Christ Incorporated
|
|
|
17,773
|
|
|
|
17,773
|
|
|
|
0
|
|
Joseph T. Lukens
|
|
|
103,880
|
|
|
|
103,880
|
|
|
|
0
|
|
Anthony V. Milone
|
|
|
6,243
|
|
|
|
6,243
|
|
|
|
0
|
|
William L. Murphee
|
|
|
5,910
|
|
|
|
5,910
|
|
|
|
0
|
|
John F. Neace
|
|
|
6,410
|
|
|
|
6,410
|
|
|
|
0
|
|
John F. Peters
|
|
|
5,994
|
|
|
|
5,994
|
|
|
|
0
|
|
William N. Richey
|
|
|
2,913
|
|
|
|
2,913
|
|
|
|
0
|
|
Royalmont Academy
|
|
|
36,725
|
|
|
|
36,725
|
|
|
|
0
|
|
Gavin Scotti
|
|
|
6,243
|
|
|
|
6,243
|
|
|
|
0
|
|
Thomas H. Siemers
|
|
|
5,994
|
|
|
|
5,994
|
|
|
|
0
|
|
James A. Stewart
|
|
|
9,157
|
|
|
|
9,157
|
|
|
|
0
|
|
Robert V. Vitale
|
|
|
2,913
|
|
|
|
2,913
|
|
|
|
0
|
|
Michael S. Vitale
|
|
|
5,993
|
|
|
|
5,993
|
|
|
|
0
|
|
Gerald L. Wolken
|
|
|
29,955
|
|
|
|
29,955
|
|
|
|
0
|
|
TOTALS:
|
|
|
522,884
|
|
|
|
522,884
|
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
The number of shares beneficially owned is determined in
accordance with
Rule 13d-3
of the Securities Exchange Act of 1934, and the information is
not necessarily indicative of beneficial ownership for any other
purpose. |
|
(2) |
|
The table assumes that the selling stockholders sell all of
their shares being offered pursuant to this prospectus. We are
unable to determine the exact number of shares that will
actually be sold pursuant to this prospectus. |
13
PLAN OF
DISTRIBUTION
The selling stockholders and any of their pledgees, assignees
and
successors-in-interest
may, from time to time, sell any or all of the shares of common
stock beneficially owned by them and offered hereby directly or
through one or more underwriters, broker-dealers or agents. If
the common stock is sold through underwriters or broker-dealers,
the selling stockholders will be responsible for underwriting
discounts or commissions or agents commissions. The common
stock may be sold in one or more transactions at fixed prices,
at prevailing market prices at the time of the sale, at varying
prices determined at the time of sale, or at negotiated prices.
The selling stockholders may use any one or more of the
following methods when selling shares:
|
|
|
|
|
on any national securities exchange or quotation service on
which the securities may be listed or quoted at the time of sale;
|
|
|
|
in the
over-the-counter
market;
|
|
|
|
in transactions otherwise than on these exchanges or systems or
in the
over-the-counter
market;
|
|
|
|
through the writing of options, whether such options are listed
on an options exchange or otherwise;
|
|
|
|
ordinary brokerage transactions and transactions in which the
broker dealer solicits purchasers;
|
|
|
|
block trades in which the broker dealer will attempt to sell the
shares as agent but may position and resell a portion of the
block as principal to facilitate the transaction;
|
|
|
|
purchases by a broker dealer as principal and resale by the
broker dealer for its account;
|
|
|
|
an exchange distribution in accordance with the rules of the
applicable exchange;
|
|
|
|
privately negotiated transactions;
|
|
|
|
through the settlement of short sales;
|
|
|
|
broker-dealers may agree with the selling stockholders to sell a
specified number of such shares at a stipulated price per share;
|
|
|
|
a combination of any such methods of sale; and
|
|
|
|
any other method permitted pursuant to applicable law.
|
The selling stockholders may also sell shares under
Rule 144 under the Securities Act, if available, rather
than under this prospectus.
In addition, the selling stockholders or their successors in
interest may enter into hedging transactions with broker-dealers
who may engage in short sales of shares in the course of hedging
the positions they assume with the selling stockholders. The
selling stockholders may also sell shares short and deliver the
shares to close out such short positions. The selling
stockholders or their successors in interest may also enter into
option or other transactions with broker-dealers that require
the delivery by such broker-dealers of the shares, which shares
may be resold thereafter pursuant to this prospectus.
Broker-dealers engaged by the selling stockholders may arrange
for other brokers-dealers to participate in sales. If the
selling stockholders effect such transactions through
underwriters, broker-dealers or agents, such underwriters,
broker-dealers or agents may receive commissions in the form of
discounts, concessions or commissions from the selling
stockholders or commissions from purchasers of the shares of
common stock for whom they may act as agent or to whom they may
sell as principal, or both (which discounts, concessions or
commissions as to particular underwriters, broker-dealers or
agents may be less than or in excess of those customary in the
types of transactions involved).
The selling stockholders may from time to time pledge or grant a
security interest in some or all of the shares of common stock
owned by them and, if they default in the performance of their
secured obligations, the pledgees or secured parties may offer
and sell the shares of common stock from time to time under this
prospectus, or under an amendment to this prospectus under
Rule 424(b)(3) or other applicable provision of
14
the Securities Act, amending, if necessary, the list of selling
stockholders to include the pledgee, transferee or other
successors in interest as selling stockholders under this
prospectus.
The selling stockholders also may transfer the shares of common
stock in other circumstances, in which case the transferees,
pledgees or other successors in interest will be the selling
beneficial owners for purposes of this prospectus.
The selling stockholders and any broker-dealers or agents that
are involved in selling the shares may be deemed to be
underwriters within the meaning of the Securities
Act in connection with such sales. In such event, any
commissions received by such broker-dealers or agents and any
profit on the resale of the shares purchased by them may be
deemed to be underwriting commissions or discounts under the
Securities Act.
The selling stockholders have informed us that none of them has
any agreement or understanding, directly or indirectly, with any
person to distribute the common stock. If any selling
stockholder notifies us that a material arrangement has been
entered into with a broker-dealer for the sale of shares through
a block trade, special offering, exchange distribution or
secondary distribution or a purchase by a broker or dealer, we
will file a prospectus supplement, if required pursuant to
Rule 424(c) under the Securities Act of 1933, setting forth:
|
|
|
|
|
the name of each of the participating broker-dealers;
|
|
|
|
the number of shares involved;
|
|
|
|
the price at which the shares were sold;
|
|
|
|
the commissions paid or discounts or concessions allowed to the
broker-dealers, where applicable;
|
|
|
|
a statement to the effect that the broker-dealers did not
conduct any investigation to verify the information set out or
incorporated by reference in this prospectus; and
|
|
|
|
any other facts material to the transaction.
|
There can be no assurance that any selling stockholder will sell
any or all of the shares of common stock registered pursuant to
the shelf registration statement, of which this prospectus forms
a part.
We are required to pay all fees and expenses incident to the
registration of the shares. We have agreed to indemnify the
selling stockholders against certain losses, claims, damages and
liabilities, including liabilities under the Securities Act, or
the selling stockholders may be entitled to contribution. We may
be indemnified by the selling stockholders against civil
liabilities, including liabilities under the Securities Act that
may arise from written information furnished to us by the
selling stockholders specifically for use in this prospectus, in
accordance with the related registration rights agreements, or
we may be entitled to contribution.
None of the selling stockholders intends to use any means of
distributing or delivering the prospectus other than by hand or
the mails, and none of the selling stockholders intends to use
any forms of prospectus other than printed prospectuses.
Once sold under the shelf registration statement, of which this
prospectus forms a part, the shares of common stock will be
freely tradeable in the hands of persons other than our
affiliates.
LEGAL
MATTERS
The validity of the shares of Common Stock offered by this
Prospectus has been passed upon for Nuance Communications, Inc.
by Garrison R. Smith, Esq., Director, Corporate Legal
Services of Nuance. Mr. Smith is paid a salary by Nuance,
is a participant in various employee benefit plans offered to
employees of Nuance generally, and has options to purchase
shares of Nuance Common Stock.
15
EXPERTS
The consolidated balance sheets of Nuance Communications, Inc.
as of September 30, 2006 and 2005, and the related
consolidated statements of operations, stockholders equity
and comprehensive income (loss), and cash flows for each of the
two years in the period ended September 30, 2006, and for
the nine-month period ended September 30, 2004,
incorporated by reference into this prospectus have been so
incorporated in reliance on the report of BDO Seidman, LLP, an
independent registered public accounting firm, given on the
authority of said firm as experts in auditing and accounting.
The consolidated financial statements of Bluestar Resources
Limited, as of December 31, 2006 and 2005, and for the
years then ended, included in Nuance Communications, Inc.s
Current Report on
Form 8-K/A
dated April 17, 2007, have been audited by S.R. Batliboi
& Associates (a member firm of Ernst & Young Global),
independent auditors, as set forth in their report thereon,
included therein, and incorporated herein by reference. Such
consolidated financial statements are incorporated herein by
reference in reliance on such report given on the authority of
such firm as experts in accounting and auditing.
The consolidated financial statements of Dictaphone Corporation
as of December 31, 2005 and 2004, and for each of the three
years in the period ended December 31, 2005 incorporated by
reference into this prospectus by reference from the Nuance
Communications, Inc. Current Report on
Form 8-K/A
dated June 2, 2006, have been audited by
PricewaterhouseCoopers LLP, an independent registered public
accounting firm, and have been so incorporated in reliance upon
the report of such firm given upon their authority as experts in
accounting and auditing.
The consolidated statements of operations, changes in
stockholders equity and cash flows of Dictaphone
Corporation and its subsidiaries for the year ended
December 31, 2003 incorporated by reference into this
prospectus by reference from the Nuance Communications, Inc.
Current Report on
Form 8-K/A
dated June 2, 2006, have been audited by Grant Thornton
LLP, an independent registered public accounting firm, and have
been so incorporated in reliance upon the report of such firm
given upon their authority as experts in accounting and auditing.
The consolidated financial statements and the related financial
statement schedules of the former Nuance Communications, Inc. as
of December 31, 2004 and 2003 and for each of the three
years in the period ended December 31, 2004 and the related
financial statement schedules incorporated in this prospectus by
reference from the Nuance Communications, Inc. (formerly known
as ScanSoft, Inc.) Current Report on
Form 8-K
dated September 15, 2005, have been audited by
Deloitte & Touche LLP, an independent registered public
accounting firm, as stated in their report, which is
incorporated herein by reference, and have been so incorporated
in reliance upon the report of such firm given upon their
authority as experts in accounting and auditing.
The audited historical financial statements of Phonetic Systems
Ltd. as of December 31, 2004 and 2003, and for each of the
three years in the period ended December 31, 2004
incorporated into this prospectus by reference from the Nuance
Communications, Inc. Current Report on
Form 8-K/A
dated April 18, 2005, have been audited by Kost Forer
Gabbay & Kasierer, a member of Ernst & Young
Global, an independent registered public accounting firm, as
stated in their report, which is incorporated herein by
reference, and have been so incorporated in reliance upon the
report of such firm given upon their authority as experts in
accounting and auditing.
WHERE YOU
CAN FIND MORE INFORMATION
We file annual, quarterly and special reports, proxy statements
and other information with the SEC. You may read and copy any
document we file at the SECs Public Reference Room in
Washington, D.C., located at 100 F Street, N.E. Please call
the SEC at
1-800-SEC-0330
for further information on the Public Reference Room. Our SEC
filings are also available to the public over the internet from
the SECs web site at www.sec.gov, or our web site
at www.nuance.com (which is not intended to be an active
hyperlink in this prospectus). The contents of our website are
not incorporated by reference in or otherwise a part of this
prospectus.
16
INFORMATION
INCORPORATED BY REFERENCE
The SEC allows us to incorporate by reference the
information we file with it, which means that we can disclose
important information to you by referring you to those
documents. The information incorporated by reference is an
important part of this prospectus, and information that we file
later with the SEC will automatically update and supersede this
information. We incorporate by reference the documents listed
below and any future filings made with the SEC under
Sections 13(a), 13(c), 14, or 15(d) of the Securities
Exchange Act of 1934 subsequent to the date of this registration
statement until the selling stockholders listed on page 13
of this
Form S-3
sell all of the shares of our common stock registered under this
prospectus:
1. Nuances registration statement on
Form 8-A,
as filed with the SEC on October 20, 1995;
2. Nuances annual report on
Form 10-K/A
for the year ended September 30, 2006, as filed with the
SEC on December 15, 2006 (as amended on January 29,
2007);
3. Nuances current report on
Form 8-K/A,
as filed with the SEC on April 18, 2005, reporting under
Item 9.01;
4. Nuances current report on
Form 8-K,
as filed with the SEC on September 16, 2005, reporting
under Items 1.01, 2.01, 2.05, 3.02, 5.02, and 9.01;
5. Nuances current report on
Form 8-K/A,
as filed with the SEC on June 2, 2006, reporting under
Item 9.01;
6. Nuances current report on
Form 8-K,
as filed with the SEC on November 8, 2006, reporting under
Items 1.01 and 9.01;
7. Nuances current report on
Form 8-K,
as filed with the SEC on December 11, 2006, reporting under
Items 3.02, 8.01 and 9.01;
8. Nuances current report on
Form 8-K,
as filed with the SEC on December 19, 2006 (as amended on
December 27, 2006), reporting under Item 5.02;
9. Nuances quarterly report on
Form 10-Q
for the quarter ended December 31, 2006, as filed with the
SEC on February 9, 2007;
10. Nuances preliminary proxy statement, as filed
with the SEC on February 15, 2007;
11. Nuances definitive proxy statement, as filed with
the SEC on February 26, 2007;
12. Nuances current report on
Form 8-K,
as filed with the SEC on February 27, 2007, reporting under
Items 1.01, 3.02, 7.01 and 9.01;
13. Nuances definitive proxy statement additional
materials, as filed with the SEC on March 15, 2007;
14. Nuances current report on
Form 8-K,
as filed with the SEC on March 15, 2007, reporting under
Items 5.02, 8.01 and 9.01;
15. Nuances current report on
Form 8-K,
as filed with the SEC on March 19, 2007, reporting under
Items 1.01 and 9.01;
16. Nuances current report on
Form 8-K,
as filed with the SEC on March 22, 2007, reporting under
Item 1.01;
17. Nuances current report on
Form 8-K,
as filed with the SEC on March 28, 2007, reporting under
Items 2.01, 5.02 and 9.01;
18. Nuances current report on
Form 8-K/A,
as filed with the SEC on April 17, 2007, reporting under
Item 9.01.
17
This prospectus is part of a registration statement on
Form S-3
filed with the SEC under the Securities Act of 1933. This
prospectus does not contain all of the information set forth in
the registration statement. You should read the registration
statement for further information about Nuance and our common
stock.
Documents incorporated by reference are available from us,
without charge, excluding all exhibits unless specifically
incorporated by reference in the documents. You may obtain
documents incorporated by reference in this prospectus by
writing to us at the following address or by calling us at the
telephone number listed below:
Nuance
Communications, Inc.
1 Wayside Road
Burlington, Massachusetts 01803
Attn: Investor Relations
(781) 565-5000
You should rely only on the information incorporated by
reference or provided in this prospectus or any prospectus
supplement. We have not authorized anyone else to provide you
with different information.
You should not assume that the information in this prospectus or
any prospectus supplement is accurate as of any date other than
the date on the front page of those documents.
18
522,884 Shares
Common Stock
PROSPECTUS
April 18, 2007
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
|
|
ITEM 14.
|
OTHER
EXPENSES OF ISSUANCE AND DISTRIBUTION.
|
The Registrant will pay all reasonable expenses incident to the
registration of the shares other than any commissions and
discounts of underwriters, dealers or agents. Such expenses are
set forth in the following table. All of the amounts shown are
estimates except the SEC registration fee.
|
|
|
|
|
|
|
Amount to
|
|
|
|
be Paid
|
|
|
SEC registration fee
|
|
$
|
258
|
|
Legal fees and expenses*
|
|
|
30,000
|
|
Accounting fees and expenses*
|
|
|
100,000
|
|
Printing expenses*
|
|
|
15,000
|
|
Miscellaneous expenses*
|
|
|
4,742
|
|
|
|
|
|
|
Total
|
|
$
|
150,000
|
|
|
|
|
|
|
|
|
ITEM 15.
|
INDEMNIFICATION
OF DIRECTORS AND OFFICERS.
|
Section 145(a) of the General Corporation Law of the State
of Delaware (Delaware Corporation Law) provides, in
general, that a corporation shall have the power to indemnify
any person who was or is a party or is threatened to be made a
party to any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or
investigative (other than an action by or in the right of the
corporation), because the person is or was a director, officer,
employee or agent of the corporation. Such indemnity may be
against expenses (including attorneys fees), judgments,
fines and amounts paid in settlement actually and reasonably
incurred by the person in connection with such action, suit or
proceeding, if the person acted in good faith and in a manner
the person reasonably believed to be in or not opposed to the
best interests of the corporation and if, with respect to any
criminal action or proceeding, the person did not have
reasonable cause to believe the persons conduct was
unlawful.
Section 145(b) of the Delaware Corporation Law provides, in
general, that a corporation shall have the power to indemnify
any person who was or is a party or is threatened to be made a
party to any threatened, pending or completed action or suit by
or in the right of the corporation to procure a judgment in its
favor because the person is or was a director, officer, employee
or agent of the corporation, against any expenses (including
attorneys fees) actually and reasonably incurred by the
person in connection with the defense or settlement of such
action or suit if the person acted in good faith and in a manner
the person reasonably believed to be in or not opposed to the
best interests of the corporation, subject to certain additional
limitations.
Section 145(g) of the Delaware Corporation Law provides, in
general, that a corporation shall have the power to purchase and
maintain insurance on behalf of any person who is or was a
director, officer, employee or agent of the corporation against
any liability asserted against the person in any such capacity,
or arising out of the persons status as such, whether or
not the corporation would have the power to indemnify the person
against such liability under the provisions of the law.
Article XI of the Restated Certificate of Incorporation, as
amended, of the Registrant authorizes the Registrant, subject to
certain limited exceptions, to indemnify its directors and
officers to the fullest extent permitted by the Delaware
Corporation Law. Article II, Section 6 of the Amended
and Restated Bylaws of the Registrant, however, require the
Registrant to indemnify its directors and officers to the
fullest extent permitted by the Delaware Corporation Law. The
directors and officers of the Registrant are insured under
policies of insurance maintained by the Registrant, subject to
the limits of the policies, against certain losses arising from
II-1
any claims made against them by reason of being or having been
such directors or officers. In addition, the Registrant has
entered into contracts with certain of its directors providing
for indemnification of such persons by the Registrant to the
full extent authorized or permitted by law, subject to certain
limited exceptions.
|
|
|
|
|
Exhibit Number
|
|
Description of Document
|
|
|
3
|
.1(1)
|
|
Amended and Restated Certificate
of Incorporation of the Registrant.
|
|
3
|
.2(2)
|
|
Certificate of Amendment of the
Amended and Restated Certificate of Incorporation of the
Registrant.
|
|
3
|
.3*
|
|
Certificate of Amendment of the
Amended and Restated Certificate of Incorporation of the
Registrant, as amended.
|
|
3
|
.4(3)
|
|
Amended and Restated Bylaws of the
Registrant.
|
|
5
|
.1*
|
|
Legal Opinion of Garrison Smith,
Director, Corporate Legal Services of Nuance Communications, Inc.
|
|
23
|
.1*
|
|
Consent of S.R.
Batliboi & Associates
|
|
23
|
.2*
|
|
Consent of BDO Seidman, LLP
|
|
23
|
.3*
|
|
Consent of PricewaterhouseCoopers
LLP
|
|
23
|
.4*
|
|
Consent of Grant Thornton LLP
|
|
23
|
.5*
|
|
Consent of Deloitte & Touche
LLP
|
|
23
|
.6*
|
|
Consent of Kost Forer
Gabbay & Kasierer
|
|
|
|
* |
|
Filed herewith |
|
(1) |
|
Incorporated by reference from the Registrants Quarterly
Report on Form
10-Q
(No. 0-27038)
for the fiscal quarter ended March 31, 2002, filed with the
Commission on May 11, 2002. |
|
(2) |
|
Incorporated by reference from the Registrants Quarterly
Report on Form
10-Q
(No. 0-27038)
for the fiscal quarter ended June 30, 2004, filed with the
Commission on August 9, 2004. |
|
(3) |
|
Incorporated by reference from the Registrants Annual
Report on Form
10-K
(No. 0-27038)
for the fiscal year ended December 31, 2003, filed with the
Commission on March 15, 2004. |
Registrant hereby undertakes:
1. To file, during any period in which offers or sales are
being made, a post-effective amendment to this Registration
Statement to include any material information with respect to
the plan of distribution not previously disclosed in the
registration statement or any material change to such
information in the registration statement.
2. That, for the purpose of determining any liability under
the Securities Act, each such post-effective amendment shall be
deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide
offering thereof.
3. To remove from registration by means of a post-effective
amendment any of the securities being registered which remain
unsold at the termination of the offering.
4. That, for purposes of determining any liability under
the Securities Act of 1933, each filing of Registrants
annual report pursuant to Section 13(a) or
Section 15(d) of the Securities Exchange Act of 1934 (and,
where applicable, each filing of an employee benefit plans
annual report pursuant to Section 15(d) of the Securities
Exchange Act of 1934) that is incorporated by reference in
the registration
II-2
statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof.
5. Insofar as indemnification for liabilities arising under
the Securities Act may be permitted to directors, officers and
controlling persons of the Registrant pursuant to the foregoing
provisions, or otherwise, the Registrant has been advised that
in the opinion of the SEC such indemnification is against public
policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the
Registrant of expenses incurred or paid by a director, officer,
or controlling person of the Registrant in the successful
defense of any action, suit, or proceeding) is asserted by such
director, officer, or controlling person in connection with the
securities being registered, the Registrant will, unless in the
opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Securities Act and
will be governed by the final adjudication of such issue.
II-3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on
Form S-3
and has duly caused this Registration Statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the
city of Burlington state of Massachusetts, on April 17,
2007.
Nuance Communications,
Inc.
Paul A. Ricci
Chair of the Board and Chief Executive Officer
POWER OF
ATTORNEY
We, the undersigned officers and directors of Nuance
Communications, Inc. hereby constitute and appoint Paul A. Ricci
and James R. Arnold, Jr., and each of them individually,
our true and lawful
attorney-in-fact,
with full power of substitution, to sign for us and in our names
in the capacities indicated below the Registration Statement
filed herewith and any and all amendments to said Registration
Statement, and generally to do all such things in our name and
behalf in our capacities as officers and directors to enable
Nuance Communications, Inc. to comply with the provisions of the
Securities Act of 1933, as amended, and all requirements of the
Securities and Exchange Commission, hereby ratifying and
confirming our signatures as they may be signed by our said
attorney to said Registration Statement and any and all
amendments thereto.
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement and Power of Attorney has been signed
below by the following persons in the capacities and on the
dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Paul
A. Ricci
Paul
A. Ricci
|
|
Chairman of the Board and Chief
Executive Officer (Principal Executive Officer)
|
|
April 17, 2007
|
|
|
|
|
|
/s/ James
R. Arnold, Jr.
James
R. Arnold, Jr.
|
|
Senior Vice President and Chief
Financial Officer (Principal Financial Officer)
|
|
April 17, 2007
|
|
|
|
|
|
/s/ Steven
E. Hebert
Steven
E. Hebert
|
|
Chief Accounting Officer
(Principal Accounting Officer)
|
|
April 17, 2007
|
|
|
|
|
|
/s/ Charles
W. Berger
Charles
Berger
|
|
Director
|
|
April 17, 2007
|
|
|
|
|
|
Robert
J. Frankenberg
|
|
Director
|
|
|
|
|
|
|
|
/s/ Jeffrey
A. Harris
Jeffrey
Harris
|
|
Director
|
|
April 16, 2007
|
|
|
|
|
|
/s/ William
H. Janeway
William
H. Janeway
|
|
Director
|
|
April 16, 2007
|
II-4
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
/s/ Katharine
A. Martin
Katharine
A. Martin
|
|
Director
|
|
April 16, 2007
|
|
|
|
|
|
Mark
B. Myers
|
|
Director
|
|
|
|
|
|
|
|
Philip
Quigley
|
|
Director
|
|
|
|
|
|
|
|
/s/ Robert
G. Teresi
Robert
G. Teresi
|
|
Director
|
|
April 16, 2007
|
II-5
EXHIBIT INDEX
|
|
|
|
|
Exhibit Number
|
|
Description of Document
|
|
|
3
|
.1(1)
|
|
Amended and Restated Certificate
of Incorporation of the Registrant.
|
|
3
|
.2(2)
|
|
Certificate of Amendment of the
Amended and Restated Certificate of Incorporation of the
Registrant.
|
|
3
|
.3*
|
|
Certificate of Amendment of the
Amended and Restated Certificate of Incorporation of the
Registrant, as amended.
|
|
3
|
.4(3)
|
|
Amended and Restated Bylaws of the
Registrant.
|
|
5
|
.1*
|
|
Legal Opinion of Garrison Smith,
Director, Corporate Legal Services of Nuance Communications, Inc.
|
|
23
|
.1*
|
|
Consent of S.R.
Batliboi & Associates
|
|
23
|
.2*
|
|
Consent of BDO Seidman, LLP
|
|
23
|
.3*
|
|
Consent of PricewaterhouseCoopers
LLP
|
|
23
|
.4*
|
|
Consent of Grant Thornton LLP
|
|
23
|
.5*
|
|
Consent of Deloitte &
Touche LLP
|
|
23
|
.6*
|
|
Consent of Kost Forer
Gabbay & Kasierer
|
|
|
|
* |
|
Filed herewith |
|
(1) |
|
Incorporated by reference from the Registrants Quarterly
Report on Form
10-Q
(No. 0-27038)
for the fiscal quarter ended March 31, 2002, filed with the
Commission on May 11, 2002. |
|
(2) |
|
Incorporated by reference from the Registrants Quarterly
Report on Form
10-Q
(No. 0-27038)
for the fiscal quarter ended June 30, 2004, filed with the
Commission on August 9, 2004. |
|
(3) |
|
Incorporated by reference from the Registrants Annual
Report on Form
10-K
(No. 0-27038)
for the fiscal year ended December 31, 2003, filed with the
Commission on March 15, 2004. |
II-6